Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy Michele MaioGeorge CoukosRamy Ibrahim Opinion Paper 18 December 2018 Pages: 1 - 9
β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress Guanxi QiaoMark J. BucsekElizabeth A. Repasky Original Article Open access 18 September 2018 Pages: 11 - 22
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up Jeong-Hoon LeeJoon Hyeok LeeJung-Hwan Yoon Original Article Open access 19 September 2018 Pages: 23 - 32
TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression Maya GershkovitzTanya Fainsod-LeviZvi Granot Original Article 24 September 2018 Pages: 33 - 43
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer Qi JiangQiang FuJiejie Xu Original Article 26 September 2018 Pages: 45 - 56
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics Sotirios P. FortisChristoforos K. VaxevanisSonia A. Perez Original Article 01 October 2018 Pages: 57 - 70
An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells Michele TomasicchioLynn SempleKeertan Dheda Original Article Open access 03 October 2018 Pages: 71 - 83
Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma Wei WangWai-Ching LamLing Chen Original Article 11 October 2018 Pages: 85 - 95
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study Maria Pia PistilloVincenzo FontanaOn behalf of the Italian Melanoma Intergroup (IMI) Original Article 11 October 2018 Pages: 97 - 107
Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer Aliyah M. WeinsteinNicolas A. GiraldoCatherine Sautès-Fridman Original Article 12 October 2018 Pages: 109 - 120
Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer Wen ZhangXu LuLin Yang Clinical Trial Report 10 October 2018 Pages: 121 - 130
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter Roberto RuiuValeria RolihLaura Conti Focussed Research Review 15 June 2018 Pages: 131 - 141
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology Anna Maria Di GiacomoAlessia CovreMichele Maio Focussed Research Review 18 December 2018 Pages: 143 - 150
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017 Michele MaioMaria Fortunata LofiegoVincenzo Russo Meeting Report 09 August 2018 Pages: 151 - 158
Prediction of neoepitopes from murine sequencing data Anne-Mette BjerregaardThomas Kainamura PedersenSine Reker Hadrup Letter to the Editors 05 October 2018 Pages: 159 - 161